Actively Recruiting
A Study of a Dietary Supplement on Serum Biomarkers in Children
Led by SF Research Institute, Inc. · Updated on 2026-02-04
30
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
Sponsors
S
SF Research Institute, Inc.
Lead Sponsor
S
Smarty Pants Vitamins
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a pilot clinical study designed to evaluate the effects of a dietary supplement on selected blood-based nutritional biomarkers in healthy children aged 4 to 15 years. Approximately 24 children will be screened and enrolled to account for potential dropouts, with a target of 20 participants completing the study. Eligible participants will attend a screening and baseline visit, followed by daily intake of the study supplement for 4 weeks. After the supplementation period, participants will return to the clinic for an end-of-study visit. Blood samples will be collected at baseline and after 4 weeks to measure nutritional biomarkers, including vitamin D, vitamin B12, folate, omega-3 fatty acids, and standard blood count parameters. Additional assessments include height, weight, body mass index (BMI), and a socioeconomic questionnaire. Throughout the study, participants or their caregivers will record daily supplement intake, any medications taken, and any adverse events in a study diary. The results of this pilot study will provide preliminary data on the effects of the dietary supplement on serum biomarkers in children.
CONDITIONS
Official Title
A Study of a Dietary Supplement on Serum Biomarkers in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy males and females aged 4 to 15 years
- Normal BMI/growth between 5th and 85th percentile according to CDC growth tables
- Able to read, understand, and complete study questionnaires and records
- Able to understand study procedures
- Able to meet all study requirements
- Written informed consent from parent/guardian and assent from child
- Willing to maintain current lifestyle habits including diet, physical activity, medications, and sleep during the study
- Willing to avoid starting new supplements during the study
- Willing to actively participate and attend scheduled visits
You will not qualify if you...
- Immune insufficiency
- Use of systemic corticosteroids or immunosuppressant drugs
- Any diseases or medications that could interfere with the study or risk participant's health
- Currently taking prescription medications or dietary supplements including multivitamins
- Employees of the study institute, product brand owner, or manufacturers
- Cardiovascular, chronic liver, thyroid, or kidney diseases
- History of cancer
- Any condition affecting ability to follow study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
San Francisco Research Institute
San Francisco, California, United States, 94132
Actively Recruiting
Research Team
D
Dr. John Ademola
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here